Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Phillip Mark Hogarth, Geoffrey A Pietersz

Research output: Contribution to journalArticleResearchpeer-review

280 Citations (Scopus)


This Review addresses various strategies to manipulate FcR function to overcome immune complex-mediated inflammatory diseases, and considers approaches to improve antibody-based anticancer therapies.
Original languageEnglish
Pages (from-to)311 - 331
Number of pages21
JournalNature Reviews Drug Discovery
Issue number4
Publication statusPublished - 2012

Cite this